Method

• US 20090134211A1
• Filed: 06/08/2006
• Published: 05/28/2009
• Est. Priority Date: 06/08/2005
• Status: Abandoned Application

• Current Assignee: Nycomed GmbH (Takeda Pharmaceutical Company Limited)
• Original Assignee: Nycomed GmbH (Takeda Pharmaceutical Company Limited)
• Inventors: Dietrich, Rango
• Application Number:
  US11/921,215
• Publication Number:
  US 20090134211A1
• Time in Patent Office: Days
• US Class Current: 235/375
• CPC Class Codes: G06K 19/04 characterised by the shape
• CPC Class Codes: G06K 19/0723 the record carrier comprising an arrangement for non-contact communication, e.g. wireless communication circuits on transponder cards, non-contact smart cards or RFIDs
• CPC Class Codes: G06K 7/0008 General problems related to the reading of electronic memory record carriers, independent of its reading method, e.g. power transfer
• CPC Class Codes: G06K 7/10435 the interrogation device being positioned close to a conveyor belt or the like on which moving record carriers are passing conveying in accordance with bodily destination marks, see B65G47/46, sorting of objects carrying identity markings, see B07C5/34

Abstract

The present invention relates to a method for the provision of clinical trial products in the context of clinical trials.

Claims

1. A method for the provision of clinical trial products in the context of clinical trials, comprising the following steps:

(a) applying one or more RFID units to a primary packaging of a trial product,

(b) arranging one or more primary packagings, obtained after step (a), inside a secondary packaging,

(c) applying one or more RFID units to the secondary packaging obtained in (b),

(d) arranging one or more secondary packagings, obtained after (c), inside a common outer packaging,

(e) optionally applying one or more RFID units to the outer packaging, and

(f) recording all the packaging components by means of the RFID units.

2. The method according to claim 1, in which the RFID units are connected to a tag, and the tag comprises a printable carrier material and a self-adhesive layer.

3. The method according to claim 2, in which the RFID unit is a pre-coded RFID unit.

4. The method according to claim 1, in which an RFID unit is applied to each of the primary packagings.

5. The method according to claim 1, in which an RFID unit is applied to each of the secondary packagings.

6. The method according to claim 1, in which the trial product is a non-approved drug.

7. The method according to claim 1, in which the trial product is a presentation form selected from the group comprising solid oral forms, inhaled forms, presentation forms for parenteral administration, semi-solid forms and transdermal therapeutic systems.

8. The method according to claim 7, involving two or more trial products.

9. The method according to claim 1, in which the primary packaging is a packaging selected from the group comprising blister packs, cartons, tubes, bottles, ampoules, stoppered vials, metered dose inhalers, drug powder inhalers, sachets and sealed pouches.

10. The method according to claim 9, involving two or more primary packagings.

11. The method according to claim 1, in which the recording carried out in step (f) is effected via an RFID reader with which the data stored on the RFID units can be read out and transferred into an electronic database.

12. The method according to claim 1, in which step (b) comprises arranging two or more primary packagings, obtained after step (a), inside a secondary packaging.

13. The method according to claim 1, in which step (d) comprises arranging two or more secondary packagings, obtained after step (c), inside a common outer packaging.

14. The method according to claim 1, in which the recording carried out in step (f) is effected in one operating step.

15. The method according to claim 1, comprising after step (f) the following steps:

(g) sending the obtained RFID specimen shipper to a clinical trial site and

(h) recording the content of the RFID specimen shipper after provision of the clinical trial products to patients.

16. A test specimen shipper comprising an outer packaging which has an RFID unit and contains one or more secondary packagings, the secondary packagings each having one or more RFID units, the secondary packagings containing one or more primary packagings, and the primary packagings having one or more RFID units.

17. The test specimen shipper according to claim 16, in which one or more trial products are contained in the primary packagings.